United Therapeutics Corporation (UTHR)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 2,877,400 | 2,327,500 | 1,936,300 | 1,685,500 | 1,483,300 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $2,877,400K ÷ $—K
= —
The receivables turnover ratio for United Therapeutics Corporation is not available for the years spanning from December 31, 2020, to December 31, 2024, as indicated by the data provided. The receivables turnover ratio is a key efficiency metric that measures how many times a company collects its accounts receivable during a specific period. Without this ratio, it is challenging to assess the effectiveness of the company in managing its receivables and converting them into cash. It is recommended to monitor this ratio in the future to gain insights into the company's receivables management performance and overall financial health.
Peer comparison
Dec 31, 2024